Vantia Therapeutics
Vantia Therapeutics is a pharmaceutical company developing small molecule drugs for unmet medical needs.
Vantia Therapeutics is a company in biotechnology, pharmaceutical, therapeutics based in Europe, Middle East, and Africa (EMEA), founded in 2007.
Its activity falls under biotechnology, pharmaceutical, therapeutics; the profile below is assembled from public directory data.
The business is associated with Europe, Middle East, and Africa (EMEA).
The company is listed at the Series_B stage of development.
Recorded headcount: c_00011_00050 employees.
It has disclosed roughly $6.5M in funding.
| Sector | Biotechnology, Pharmaceutical, Therapeutics |
|---|---|
| Headquarters | Europe, Middle East, and Africa (EMEA) |
| Founded | 2007 |
| Employees | c_00011_00050 |
| Stage | series_b |
| Total funding | $6,500,000 |
Website: www.vantia.com
Full contact details are available to registered Pixilab members.
Create a free account
Create a free account